This Article Full Text Full Text (PDF) All Versions of this Article: 40/9/3102    most recent STROKEAHA.109.553958v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Bråtane, B. T. Articles by Fisher, M. PubMed PubMed Citation Articles by Bråtane, B. T. Articles by Fisher, M. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Stroke Related Collections Animal models of human disease Embolic stroke Computerized tomography and Magnetic Resonance Imaging Neuroprotectors

(Stroke. 2009;40:3102.)
© 2009 American Heart Association, Inc.

Original Contributions

Granulocyte-Colony Stimulating Factor Delays PWI/DWI Mismatch Evolution and Reduces Final Infarct Volume in Permanent-Suture and Embolic Focal Cerebral Ischemia Models in the Rat

Bernt T. Bråtane, MSc; James Bouley, BSc; Armin Schneider, MD; Birgul Bastan, MD; Nils Henninger, MD Marc Fisher, MD

From the Department of Neurology (B.T.B., J.B., B.B., N.H., M.F.), University of Massachusetts Medical School, Worcester, Mass, and Molecular Neurology (A.S.), Sygnis Bioscience GmbH & Co KG, Heidelberg, Germany.

Correspondence to Bernt Tore Bratane, Center for Comparative Neuroimaging, University of Massachusetts Medical School, 303 Belmont St, Worcester, MA 01604. E-mail Bernt.Bratane{at}umassmed.edu

Background and Purpose— Granulocyte-colony stimulating factor (G-CSF) is used clinically to attenuate neutropenia after chemotherapy. G-CSF acts as a growth factor in the central nervous system, counteracts apoptosis, and is neuroprotective in rodent transient ischemia models.

Methods— We assessed the effect of G-CSF on ischemic lesion evolution in a rat permanent-suture occlusion model with diffusion- and perfusion-weighted magnetic resonance imaging and the neuroprotective effect of G-CSF in a rat embolic stroke model.

Results— With a constant perfusion deficit, vehicle-treated animals showed an expanding apparent diffusion coefficient lesion volume that matched the perfusion deficit volume at 3 hours, with the 24-hour infarct volume equivalent to the perfusion deficit. In G-CSF–treated rats, the apparent diffusion coefficient lesion volume did not increase after treatment initiation, and the infarct volume at 24 hours reflected the initial apparent diffusion coefficient lesion volume. In the embolic model, we observed a significant decrease in infarct volume in G-CSF–treated animals compared with the vehicle-treated group.

Conclusions— These results confirm the potent neuroprotective activity of G-CSF in different focal ischemia models. The magnetic resonance imaging data demonstrate that G-CSF preserved the perfusion/diffusion mismatch.

Key Words: G-CSF • growth factors • stroke • cerebral ischemia • diffusion-weighted imaging • perfusion-weighted imaging • penumbra • mismatch